Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announces the completion of its financial restructuring process and emergence from Chapter 11 protection. Through the restructuring process, Inotiv has reduced its debt by approximately $326 million and significantly strengthened its capital structure. Inotiv emerges with the support of its existing stakeholders, who collectively manage more than $60 billion in assets, and who provided additional capital to support the Company and its long-term vision and growth initiatives.
Read the full article: Inotiv Successfully Completes Financial Restructuring Process //
Source: https://www.businesswire.com/news/home/20260719371664/en/Inotiv-Successfully-Completes-Financial-Restructuring-Process